A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 84
- Population
- ALL · 65 Years to 80 Years
- Duration
- 2026-08-01 to 2027-02-28
- Intervention
- Remimazolam; propofol
- Comparator
- Propofol (Group P)
- Outcomes measured
- Total sleep time (TST) on the first postoperative night — On the first postoperative night; Richards-Campbell Sleep Questionnaire (RCSQ) Score — Postoperative Day 1, Postoperative Day 2, Postoperative Day 3, Pos…; Pittsburgh Sleep Quality Index (PSQI) Score — 1 month postoperatively; Resting Visual Analogue Scale (VAS) Pain Score — at 1, 2, and 3 days postoperatively; The incidence of postoperative delirium — at 1, 2, and 3 days postoperatively; Postoperative cognitive function — at 7 days postoperatively and at 1 month postoperatively; Sleep efficiency assessed by polysomnography (PSG) — Postoperative Night 1; Number of awakenings after sleep onset assessed by polysomnography (PSG) — Postoperative Night 1; Total wake time assessed by polysomnography (PSG) — Postoperative Night 1; Proportion of each sleep stage assessed by polysomnography (PSG) — Postoperative Night 1; Serum levels of cortisol — on the morning of postoperative day 1; Movement Visual Analogue Scale (VAS) Pain Score — Postoperative Day 1, Postoperative Day 2, Postoperative Day 3; Serum C-reactive protein (CRP) level — Morning of postoperative day 1; Serum interleukin-6 (IL-6) level — Morning of postoperative day 1
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sleep · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.
